Publication | Closed Access
Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment.
223
Citations
0
References
1990
Year
Psychological Co-morbiditiesCore SymptomsPsychopathologyPsychiatryAnxiety SymptomsPsychopharmacologyDepressionComorbid Psychiatric DisorderSocial SciencesAlprazolam TreatmentPsychiatric DisorderDrug TreatmentMedicinePsychologyDouble-blind Crossover TrialPost-traumatic Stress Disorder
The authors report a random-assignment, double-blind crossover trial comparing alprazolam and placebo in posttraumatic stress disorder (PTSD). Ten patients fulfilling DSM-III criteria for PTSD completed 5 weeks of treatment on each agent. Improvement in anxiety symptoms was significantly greater during alprazolam treatment but modest in extent. Symptoms specific to PTSD were not significantly altered. The impact of nonspecific symptomatic effects on the outcome of drug trials in PTSD is considered.